Pulmonary Hypertension - The Left Main and Coronary Artery Bifurcation Lesion Summit (CBS)

Abstract

rhACE2 Therapy Modifies Bleomycin-Induced Pulmonary Hypertension via Rescue of Vascular Remodeling
Pulmonary Artery Denervation for Patients With Residual Pulmonary Hypertension After Pulmonary Endarterectomy
Percutaneous Pulmonary Angioplasty for Patients With Takayasu Arteritis and Pulmonary Hypertension
Pulmonary Artery Denervation for Pulmonary Arterial Hypertension: A Sham-Controlled Randomized Trial
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Hemodynamic, Functional, and Clinical Responses to Pulmonary Artery Denervation in Patients With Pulmonary Arterial Hypertension of Different Causes
Treatment Effects of Pulmonary Artery Denervation for Pulmonary Arterial Hypertension Stratified by REVEAL Risk Score: Results from PADN-CFDA Trial

|<< 1 2 3 4 5 6 7 8 >>|

Review Article

2005 Feb;16(1):13-8.

JOURNAL：Coron Artery Dis.

Article Link

The right ventricle in pulmonary hypertension

Chin KM, Kim NH, Rubin LJ.

2614

Keywords: pulmonary arterial hypertension; right ventricle function;

ABSTRACT

Pulmonary arterial hypertension (PAH) is a term used to classify a variety of conditions that share in common an injury to the pulmonary vasculature that produces elevations in pulmonary arterial pressure. However, it is the integrity of right ventricular function, rather than the degree of vascular injury, that is the major determinant of symptoms and survival in PAH. The article will review the normal structure and function of the right ventricle and summarize the impact of PAH and its treatments on right ventricular function.